ALFA Finder
India's fastest NSE & BSE filing alerts on Telegram, filtered to the stocks you hold
Telegram alerts
alfafinder.com →
ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
29 announcements with these filters
Shivalik Rasayan intimated a board meeting on 13 November 2026 to approve unaudited standalone and consolidated results for the quarter and half year ended 30 September 2026. The trading window remains closed until 48 hours after results.
Shivalik Rasayan achieved USFDA Complete Assessment for its Avapritinib API Drug Master File. The API is used in Sanofi's GIST treatment Ayvakit.
The company filed its quarterly shareholding pattern for the quarter ended September 30, 2026, as required under SEBI listing regulations.
Ginnerup Capital ApS acquired 3,99,990 fully convertible warrants of Shivalik Rasayan Limited. The acquisition via preferential allotment represents a 5.34% stake on a diluted basis.
Shivalik Rasayan Limited conducted its 48th Annual General Meeting on September 28, 2026. Key resolutions included the adoption of financial statements and declaration of a 10% dividend.
Shivalik Rasayan Ltd filed its quarterly shareholding pattern as per SEBI regulations. This is a routine compliance disclosure.
Shivalik Rasayan Limited allotted 2,82,000 equity shares and 9,47,990 fully convertible warrants via a preferential issue at Rs. 250 per security. This issuance increases the company's paid-up capital.
Shivalik Rasayan allotted 2,82,000 equity shares and 9,47,990 warrants on a preferential basis, raising Rs. 30.75 Crore in new capital for the company.
Shivalik Rasayan Limited has issued the notice for its 48th Annual General Meeting, scheduled for September 28, 2026. It also announced the annual report disclosure.
Mr. Sanjay Bansal, a former Director of Shivalik Rasayan Limited, sold 25,000 equity shares via the open market. The transaction was valued at approximately ₹0.68 Crore.
Shivalik Rasayan Limited announced the voting results for its EGM held on August 20, 2026, approving the issuance of equity shares and convertible warrants.
Shivalik Rasayan Limited has scheduled its 48th Annual General Meeting for September 28, 2026. It also fixed September 21, 2026, as the record date for dividend payment.
Shivalik Rasayan Limited has submitted its Business Responsibility and Sustainability Report for the financial year ending March 31, 2026, to the stock exchanges.
Shivalik Rasayan Ltd reported revenue from operations of ₹96.3 Cr (+7.8% YoY) and net profit of ₹4.5 Cr (+60.7% YoY) for Q1 FY27.
Shivalik Rasayan Limited scheduled a board meeting on August 14, 2026. The board will consider Q1 FY26 financial results and the annual report for FY26.
Former Director Sanjay Bansal sold 50,000 equity shares in the open market for Rs. 1.25 Crore. The disclosure complies with SEBI PIT Regulation 7(3).
Mr. Sanjay Bansal, a former director, disclosed the sale of 60,000 equity shares in the open market. The transaction is valued at ₹1.55 Crore.
Shivalik Rasayan Ltd will hold an EGM on August 20, 2026, to seek shareholder approval for raising Rs. 33 Crore via preferential equity and warrant issues.
Shivalik Rasayan Limited has convened an Extraordinary General Meeting (EGM) on August 20, 2026, to approve the preferential issuance of equity shares and convertible warrants.
Shivalik Rasayan Limited is raising ₹33 Crore through a preferential issue of 1,320,000 equity shares and convertible warrants to eight investors.
Shivalik Rasayan Ltd's board approved a preferential issue of 3.72 lakh equity shares and 9.48 lakh convertible warrants, raising a total of approximately ₹33 Crore.
Shivalik Rasayan will hold a board meeting on July 23, 2026, to consider proposals for fund-raising through equity shares or convertible securities.
Former Director Sanjay Bansal sold 40,000 equity shares of Shivalik Rasayan via the open market. The transaction was valued at ₹1.02 Crore.
Shivalik Rasayan's board recommended a final dividend of 0.1 per equity share for FY 2025-26. This payout remains subject to shareholder approval at the general meeting.
Shivalik Rasayan appointed Arun Agarawal & Co as Internal Auditor and accepted Director Sanjay Bansal's resignation. These board-approved leadership changes are effective immediately.
Mr. Sanjay Bansal resigned as Non-Executive Director effective May 27, 2026, citing personal reasons. The board accepted his resignation from the close of business hours.
Shivalik Rasayan Ltd reported revenue from operations of ₹102.8 Cr (+48.1% YoY) and net profit of ₹7.2 Cr (+38.5% YoY) for Q4 FY26.
Shivalik Rasayan approved audited FY26 results and recommended a 10% final dividend. The board also reconstituted committees following the resignation of director Sanjay Bansal.
Shivalik Rasayan scheduled a board meeting for May 27, 2026, to approve audited annual financial results. Directors will also consider recommending a final dividend for FY2025-26.